Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)
1.980
-0.220
(-10.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 656,348 |
Open | 2.080 |
Bid (Size) | 1.900 (1) |
Ask (Size) | 2.000 (2) |
Prev. Close | 2.200 |
Today's Range | 1.965 - 2.129 |
52wk Range | 1.920 - 11.20 |
Shares Outstanding | 43,269,200 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 16, 2024
Crude Oil Down 1%; Webuy Global Shares Spike Higher
December 16, 2024
Why Is Larimar Therapeutics Stock Trading Lower On Monday?
December 16, 2024
Recap: Larimar Therapeutics Q4 Earnings
March 14, 2024
Frequently Asked Questions
Is Larimar Therapeutics, Inc. - Common Stock publicly traded?
Yes, Larimar Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Larimar Therapeutics, Inc. - Common Stock trade on?
Larimar Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Larimar Therapeutics, Inc. - Common Stock?
The ticker symbol for Larimar Therapeutics, Inc. - Common Stock is LRMR on the Nasdaq Stock Market
What is the current price of Larimar Therapeutics, Inc. - Common Stock?
The current price of Larimar Therapeutics, Inc. - Common Stock is 1.980
When was Larimar Therapeutics, Inc. - Common Stock last traded?
The last trade of Larimar Therapeutics, Inc. - Common Stock was at 04/03/25 04:00 PM ET
What is the market capitalization of Larimar Therapeutics, Inc. - Common Stock?
The market capitalization of Larimar Therapeutics, Inc. - Common Stock is 85.67M
How many shares of Larimar Therapeutics, Inc. - Common Stock are outstanding?
Larimar Therapeutics, Inc. - Common Stock has 86M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.